Key Clues to Muscle Regeneration Found

[Guest guest]

Joslin and Stanford Researchers Find Key Clues to Muscle Regeneration;

Discovery May One Day Lead to New Ways to Treat Degenerative Diseases

BOSTON--(BUSINESS WIRE)--Nov. 11, 2004--Scientists at Stanford

University and Joslin Diabetes Center are providing new insights into

how muscle cells regenerate--leading to powerful tools to help

scientists better understand diseases such as muscular dystrophy.

Skeletal muscle contains a complex array of cell types. Among its

principal components are multi-nucleated muscle fibers and muscle

satellite cells--cells located in close association with muscle fibers

and containing precursors capable of giving rise to new muscle fibers.

" Our studies show that only the satellite cells, located near muscle

fibers, can give rise to new muscle cells. Contrary to previous studies,

precursor cells from bone marrow or other blood-forming tissues did not

change their destiny to become muscle cells, " said Amy J. Wagers, Ph.D.,

Investigator in the Developmental and Stem Cell Biology Research Section

at Joslin Diabetes Center and Assistant Professor of Pathology at

Harvard Medical School, the principal investigator of a study published

in the Nov. 12 edition of Cell. The research, which originated in the

laboratory of Irving L. Weissman, M.D., at Stanford University, now

continues at Joslin Diabetes Center in Boston.

Over the past few years, several research groups have reported that stem

cells found in the bone marrow could repair damaged muscle cells. This

had raised hopes that the well-characterized blood-forming stem cells

could be used therapeutically to treat muscular diseases. Dr. Wagers'

work disputes these past results, showing that bone marrow stem cells do

move to the muscle but don't regularly participate in repairing muscle

damage.

In the first part of the Dr. Wagers' latest study, the researchers

isolated muscle satellite cells from mice and marked them with a

substance that glows in fluorescent light. They also generated adult

bone-marrow cells and blood-forming stem cells that carried the

fluorescent markers. They then examined the capacity of these three

different cell types to generate new muscle cells in cell culture or in

mice that had injured muscle tissue.

" The results show that adult stem cells that are committed to the blood

lineage do not normally differentiate into muscle cells, " said Dr.

Wagers. " The only cells that had full potential to generate muscle cells

were derived from muscle, not from transplanted bone-marrow or

blood-forming stem cells. "

Armed with this information, the researchers looked for the exact cells

involved. To do this, they developed a new method that uses a set of

unique cell-surface markers. This method allowed them to isolate and

distinguish a subset of muscle precursor cells that give rise, at high

frequency, to new muscle cells.

They found a precise cell type--the precursor to new muscle growth. In

fact, a single cell from this subset could alone generate a sizable

colony of new muscle cells.

" Identifying this precursor of new muscle cells gives us new research

tools for future studies, including those in humans, " said Dr. Wagers.

" As we learn more about the genes expressed by these cells and the

pathways involved in regulating them, we can learn more about muscle

cell injury and regeneration. This may give us a better understanding of

what goes wrong in degenerative diseases such as muscular dystrophy,

leading possibly to new ways to treat such diseases. "

The Research Team

This research initiative, which originated at Stanford University, is

now underway at Joslin Diabetes Center in the laboratory of Dr. Wagers.

The study's first author was I. Sherwood, currently a graduate

student in the Department of Molecular and Cellular Biology at Harvard

University. Other investigators included L. Christensen, Ph.D.,

currently at Cellerant Therapeutics; Irina M. Conboy, Ph.D., an

Assistant Professor in the Department of Bioengineering at University of

California-Berkeley; J. Conboy, Ph.D., a postdoctoral fellow at

Stanford University; A. Rando, M.D., Ph.D., Associate Professor

of Neurology and Neurological Sciences at Stanford; and Irving L.

Weissman, M.D., Professor of Pathology and Developmental Biology at

Stanford. Funding for this study was provided in part through grants

from the National Institutes of Health, the Department of Veterans

Affairs, and the Burroughs Wellcome Fund.